Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Ningetinib |
Synonyms | |
Therapy Description |
Ningetinib (CT053PTSA) inhibits MET, VEGFR2, and AXL, which potentially reduces tumor cell growth (PMID: 36341335). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Ningetinib | CT053PTSA|CT-053-PTSA | AXL Inhibitor 30 MET Inhibitor 59 VEGFR2 Inhibitor 37 | Ningetinib (CT053PTSA) inhibits MET, VEGFR2, and AXL, which potentially reduces tumor cell growth (PMID: 36341335). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|